Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T3YS
|
||||
Former ID |
DNC000444
|
||||
Drug Name |
CL-385004
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C26H21FN4O2
|
||||
Canonical SMILES |
CC1=C(C=C(C=C1)F)C(=O)NC2=NC=C(C=C2)C(=O)N3CC4=CC=CN4CC<br />5=CC=CC=C53
|
||||
InChI |
1S/C26H21FN4O2/c1-17-8-10-20(27)13-22(17)25(32)29-24-11-9-18(14-28-24)26(33)31-16-21-6-4-12-30(21)15-19-5-2-3-7-23(19)31/h2-14H,15-16H2,1H3,(H,28,29,32)
|
||||
InChIKey |
XJZRYHGTQLKUDO-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Vasopressin V2 receptor | Target Info | Antagonist | [1] | |
Vasopressin V1a receptor | Target Info | Antagonist | [1] | ||
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Vasopressin-regulated water reabsorptionhsa04020:Calcium signaling pathway | |||||
Vascular smooth muscle contraction | |||||
Pathway Interaction Database | Arf6 trafficking events | ||||
PathWhiz Pathway | Vasopressin Regulation of Water Homeostasis | ||||
Reactome | Vasopressin-like receptors | ||||
G alpha (s) signalling events | |||||
Vasopressin regulates renal water homeostasis via AquaporinsR-HSA-388479:Vasopressin-like receptors | |||||
G alpha (q) signalling events | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Regulation of Water Balance by Renal Aquaporins | |||||
Peptide GPCRs | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands. Prog Brain Res. 2002;139:197-210. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.